The FDA recently approved the first treatment in nearly 30 years for acute stroke, and the agency also approved a novel drug ...
This approval augments Biocon Pharma's complex injectables portfolio and reinforces its footprint in the US pharma market.
Two companies have received approved for a generic of the 2.5 mg tablet of anticoagulant rivaroxaban, which is used to reduce the risk of stroke and deep vein thrombosis.
macOS Sequoia has been available for compatible Macs since September 2024, but further updates to Sequoia are expected over the next few months, with the latest major update being macOS 15.3 ...
In the last month, the price declined by 7.76%. ETMarkets.com Lupin share price: The company has launched its Rivaroxaban Tablets USP, 2.5mg, in the United States. The shares of Indian pharmaceutical ...
The iPhone 15 comes with 6.1-inch OLED display and Apple Bionic 16 processor. On the Back there is a Dual camera setup with 48MP main camera and 12MP Ultra-wide sensor.
The company also got tentative approval for Rivaroxaban. Despite recent stock declines, analysts suggest a potential 22% upside. Biocon's Q3 profits dropped sharply due to a previous one-time gain.
Lenalidomide capsules, in 2.5 mg, 5 mg, 10 mg, 15 mg, 20 mg and 25 mg strengths. Lenalidomide is a medication used to treat types of multiple myeloma, mantle cell lymphoma, follicular lymphoma, ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window The FDA ...
Chinese smartphone maker Xiaomi on Sunday (March 2, 2025) showcased the Xiaomi 15 Ultra and Xiaomi 15 at the ongoing Mobile World Congress (MWC) 2025. The new Xiaomi 15 series brings the Leica ...
Xiaomi is set to unveil its flagship smartphones, the Xiaomi 15 and Xiaomi 15 Ultra, in India on March 11, 2025. The devices feature advanced camera technology, powerful Snapdragon 8 Elite chipset ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results